Our mission is to discover drugs for high unmet medical needs that will improve quality of life for patients with Rare Diseases.

We stand out by our ability to deliver high value products with relatively little cost in a short period of time, due to our model we reduce the risk of drug development.

SOM Biotech has a strong pipeline of products focused on CNS at preclinical and clinical stages.

NEWS & PRESS RELEASES

Rare Disease Day 2019

Today, February 28th, is Rare Disease Day, and SOM Biotech is one with Eurordis in […]

Visit our news and press releases archive

GO TO ARCHIVE